Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
This grant funds the development of cancer-relevant technologies to accelerate their commercialization.
About this program
The SBIR Phase IIB Bridge Awards aim to support small businesses in advancing their cancer-relevant technologies towards commercialization. This funding opportunity is designed for projects that have already demonstrated feasibility and are ready to move into the next phase of development. The program encourages innovation and aims to bridge the gap between research and market readiness, ultimately benefiting patients and healthcare providers by bringing new solutions to the cancer treatment landscape. Eligible applicants include small businesses that are engaged in the development of technologies that can significantly impact cancer treatment and care. The grant provides financial support to help these businesses overcome the challenges of transitioning from research to commercial viability. By fostering collaboration between researchers and industry, the program seeks to enhance the effectiveness of cancer therapies and improve patient outcomes.
Eligibility
Small businesses engaged in the development of cancer-relevant technologies.